Payment overview · 2025
General Payments
$14.79
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kenneth Travis Johnson, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · PINEVILLE, LA · NPI 1932182201
Verified facts
What the public records show
CMS Open Payments records show Kenneth Travis Johnson, M.D. received $14.79 in general payments during 2025 across 1 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $14.79 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.79 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.79 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 521 | 129 |
| Alprazolam | Alprazolam | 492 | 105 |
| Atorvastatin Calcium | Atorvastatin Calcium | 471 | 130 |
| Pantoprazole Sodium | Pantoprazole Sodium | 402 | 112 |
| Losartan Potassium | Losartan Potassium | 392 | 102 |
| Lisinopril | Lisinopril | 318 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 303 | 83 |
| Metformin Hcl | Metformin Hcl | 301 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 283 | 68 |
| Tramadol Hcl | Tramadol Hcl | 283 | 68 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 272 | 41 |
| Potassium Chloride | Potassium Chloride | 265 | 74 |
| Omeprazole | Omeprazole | 257 | 73 |
| Mirtazapine | Mirtazapine | 254 | 74 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 253 | 69 |
| Montelukast Sodium | Montelukast Sodium | 241 | 61 |
| Tizanidine Hcl | Tizanidine Hcl | 235 | 66 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 225 | 68 |
| Sertraline Hcl | Sertraline Hcl | 209 | 65 |
| Gabapentin | Gabapentin | 208 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 191 | 47 |
| Clonazepam | Clonazepam | 186 | 34 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 179 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 179 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 176 | 51 |
| Duloxetine Hcl | Duloxetine Hcl | 174 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 162 | 41 |
| Bupropion Xl | Bupropion Hcl | 147 | 38 |
| Furosemide | Furosemide | 146 | 45 |
| Trazodone Hcl | Trazodone Hcl | 136 | 48 |
| Simvastatin | Simvastatin | 134 | 37 |
| Clonidine Hcl | Clonidine Hcl | 118 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 111 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 108 | 27 |
| Ondansetron Odt | Ondansetron | 108 | 36 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 106 | 32 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 100 | 30 |
| Meloxicam | Meloxicam | 98 | 25 |
| Jardiance | Empagliflozin | 97 | 28 |
| Ozempic | Semaglutide | 97 | 19 |
| Ibuprofen | Ibuprofen | 96 | 27 |
| Famotidine | Famotidine | 94 | 29 |
| Prednisone | Prednisone | 94 | 71 |
| Finasteride | Finasteride | 93 | 31 |
| Temazepam | Temazepam | 93 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 32 |
| Glimepiride | Glimepiride | 92 | 29 |
| Chlorthalidone | Chlorthalidone | 90 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 90 | 23 |
| Alendronate Sodium | Alendronate Sodium | 85 | 25 |
| Allopurinol | Allopurinol | 84 | 24 |
| Pregabalin | Pregabalin | 81 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 17 |
| Ezetimibe | Ezetimibe | 79 | 22 |
| Eliquis | Apixaban | 77 | 15 |
| Valsartan | Valsartan | 76 | 23 |
| Carvedilol | Carvedilol | 74 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 74 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 73 | 22 |
| Estradiol | Estradiol | 70 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 68 | 20 |
| Celecoxib | Celecoxib | 59 | 21 |
| Trulicity | Dulaglutide | 59 | 13 |
| Xarelto | Rivaroxaban | 59 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 56 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 55 | 21 |
| Atenolol | Atenolol | 54 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 54 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 18 |
| Donepezil Hcl | Donepezil Hcl | 51 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 50 | 19 |
| Synthroid | Levothyroxine Sodium | 50 | 11 |
| Aripiprazole | Aripiprazole | 49 | 18 |
| Nystatin | Nystatin | 49 | 28 |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | suppressed |
| Topiramate | Topiramate | 47 | suppressed |
| Spironolactone | Spironolactone | 46 | suppressed |
| Nifedipine Er | Nifedipine | 45 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | 12 |
| Azithromycin | Azithromycin | 43 | 31 |
| Testosterone Cypionate | Testosterone Cypionate | 42 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 41 | 13 |
| Mupirocin | Mupirocin | 41 | 24 |
| Sumatriptan Succinate | Sumatriptan Succinate | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 40 | 11 |
| Lubiprostone | Lubiprostone | 40 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 40 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 39 | 30 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | 11 |
| Memantine Hcl | Memantine Hcl | 38 | suppressed |
| Amoxicillin | Amoxicillin | 37 | 32 |
| Eszopiclone | Eszopiclone | 37 | suppressed |
| Lorazepam | Lorazepam | 36 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 35 | 14 |
| Fluconazole | Fluconazole | 35 | 25 |
| Linzess | Linaclotide | 35 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 26 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | 14 |
| Diazepam | Diazepam | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | suppressed |
| Sucralfate | Sucralfate | 30 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 25 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 28 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 27 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | 11 |
| Ramipril | Ramipril | 27 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Colchicine | Colchicine | 26 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 26 | suppressed |
| Lovastatin | Lovastatin | 26 | suppressed |
| Methocarbamol | Methocarbamol | 26 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 25 | 25 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Modafinil | Modafinil | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 23 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 11 |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 19 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Cephalexin | Cephalexin | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 18 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Ibu | Ibuprofen | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 15 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 12 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Fluocinonide | Fluocinonide | 13 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Veozah | Fezolinetant | 13 | suppressed |
| Victoza 3-Pak | Liraglutide | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Zypitamag | Pitavastatin Magnesium | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.79 · 1 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error